Academia Open
Vol 10 No 1 (2025): June (In Progress)
Medicine

A Comprehensive Review of Vitamin C in Autoimmune Skin Disease Management
Tinjauan Komprehensif tentang Vitamin C dalam Manajemen Penyakit Kulit Autoimun


View Article
  • Emad M . Eltayef*,
  • Zaizafoon N. Nasif
Emad M . Eltayef
Department of Chemistry, College of Science, Mustansiriyah University, Iraq *
Zaizafoon N. Nasif
Department of Chemistry, College of Science, Mustansiriyah University, Iraq

(*) Corresponding Author
Picture in here are illustration from public domain image or provided by the author, as part of their works
DOI: https://doi.org/10.21070/acopen.10.2025.10731
Published March 4, 2025
Keywords
  • Vitamin C,
  • ascorbic acid,
  • systemic lupus erythematosus,
  • psoriasis,
  • autoimmune skin disease,
  • pemphigus,
  • scleroderma,
  • dermatomyositis,
  • vasculitis,
  • vitiligo
    • ...More
    Less
How to Cite
Eltayef, E. M. ., & Nasif, Z. N. (2025). A Comprehensive Review of Vitamin C in Autoimmune Skin Disease Management. Academia Open, 10(1), 10.21070/acopen.10.2025.10731. https://doi.org/10.21070/acopen.10.2025.10731

Copyright (c) 2025 Emad M . Eltayef, Zaizafoon N. Nasif

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Abstract

General Background: Autoimmune skin diseases significantly impact patients' quality of life and, in severe cases, contribute to increased morbidity and mortality. While these diseases remain incurable, management strategies improve patient outcomes. Specific Background: Vitamin C (ascorbic acid), a key antioxidant, has been recognized for its role in disease management, yet its effectiveness compared to other supplements, such as vitamins D and E, remains underexplored. Knowledge Gap: Previous studies have not comprehensively evaluated the potential of vitamin C in autoimmune skin disease management, particularly in varying delivery methods and dosage effects. Aims: This review systematically examines the role of vitamin C in treating autoimmune skin diseases, synthesizing data from peer-reviewed studies, systematic reviews, and authoritative reports. Results: Vitamin C modulates innate and adaptive immunity, enhances collagen synthesis, supports skin wound healing, and regulates inflammatory processes. However, its instability and low bioavailability pose challenges that require targeted drug delivery strategies. Novelty: Unlike prior research, this review consolidates evidence on the therapeutic potential of vitamin C, addressing its limitations and proposing integrative approaches. Implications: Findings highlight the need for optimized delivery methods and further research into vitamin C’s role in autoimmune disorders, offering a potential alternative strategy for improving disease management.

Higlights:

 

  1. Autoimmune skin diseases affect quality of life and lack cures.
  2. Review vitamin C's role in managing autoimmune skin diseases.
  3. Vitamin C aids immunity and healing but requires optimized delivery methods.

Keywords: Vitamin C, ascorbic acid, systemic lupus erythematosus, psoriasis, autoimmune skin disease, pemphigus, scleroderma, dermatomyositis, vasculitis, and vitiligo.

 

View Article

Downloads

Download data is not yet available.

Metrics

No metrics found.

Plum Print visual indicator of research metrics
No metrics available.
-
see details

References

  1. A. Ali et al., “Potential of ascorbic acid in human health against different diseases: an updated narrative review,” Int. J. Food Prop., vol. 27, no. 1, pp. 493–515, Dec. 2024, doi: 10.1080/10942912.2024.2327335.
  2. S. Isola, L. Gammeri, F. Furci, S. Gangemi, G. Pioggia, and A. Allegra, “Vitamin C Supplementation in the Treatment of Autoimmune and Onco-Hematological Diseases: From Prophylaxis to Adjuvant Therapy.,” Int. J. Mol. Sci., vol. 25, no. 13, Jul. 2024, doi: 10.3390/ijms25137284.
  3. S. Agnihotri, J. Kaur, P. Masand, Anurag, V. K. Parihar, and A. Sharma, “Vitamins strategies for psoriasis: An update on current scientific evidence,” J. Holist. Integr. Pharm., vol. 4, no. 4, pp. 299–309, 2023, doi: https://doi.org/10.1016/j.jhip.2024.01.005.
  4. A. A. Kajdas, A. Żebrowska, A. Zalewska-Janowska, and A. Czerwonogrodzka-Senczyna, “The Role of Nutrition in the Pathogenesis and Treatment of Autoimmune Bullous Diseases-A Narrative Review.,” Nutrients, vol. 16, no. 22, Nov. 2024, doi: 10.3390/nu16223961.
  5. A. Białczyk, A. Wełniak, B. Kamińska, and R. Czajkowski, “Oxidative Stress and Potential Antioxidant Therapies in Vitiligo: A Narrative Review,” Mol. Diagn. Ther., vol. 27, no. 6, pp. 723–739, 2023, doi: 10.1007/s40291-023-00672-z.
  6. S. Ravetti, C. Clemente, S. Brignone, L. Hergert, D. Allemandi, and S. Palma, “Ascorbic Acid in Skin Health,” Cosmetics, vol. 6, no. 4. 2019. doi: 10.3390/cosmetics6040058.
  7. E. Ávalos-Díaz and R. Herrera Esparza, “Dermatological autoimmune diseases,” in Autoimmunity: From Bench to Bedside, El Rosario University Press, 2013, p. Chapter 34. [Online]. Available: https://www.ncbi.nlm.nih.gov/books/NBK459479/
  8. F. Diotallevi and A. Offidani, “Skin, Autoimmunity and Inflammation: A Comprehensive Exploration through Scientific Research,” International journal of molecular sciences, vol. 24, no. 21. Switzerland, Nov. 2023. doi: 10.3390/ijms242115857.
  9. F. Diotallevi et al., “The Role of Nutrition in Immune-Mediated, Inflammatory Skin Disease: A Narrative Review.,” Nutrients, vol. 14, no. 3, Jan. 2022, doi: 10.3390/nu14030591.
  10. M. Zarei et al., “Evaluation of Vitamin D Status in Newly Diagnosed Pemphigus Vulgaris Patients.,” Iran. J. Public Health, vol. 43, no. 11, pp. 1544–1549, Nov. 2014.
  11. M. H. M. El-Komy, N. Samir, and O. G. Shaker, “Estimation of vitamin D levels in patients with pemphigus vulgaris.,” J. Eur. Acad. Dermatol. Venereol., vol. 28, no. 7, pp. 859–863, Jul. 2014, doi: 10.1111/jdv.12179.
  12. A. M. Shirani, M. Khosravi, M. Ardestani, and F. Ashtari, “Pemphigus Vulgaris in a Patient with Multiple Sclerosis: A Case Report with 7 Years of Follow Up TT -,” J-Res-Dent-Maxillofac-Sci, vol. 8, no. 4, pp. 286–290, Nov. 2023, doi: 10.61186/jrdms.8.4.286.
  13. F. Dhaffouli et al., “Unraveling the role of the vitamin D-VDR pathway in pemphigus vulgaris from Tunisian patients,” Steroids, vol. 209, p. 109454, 2024, doi: https://doi.org/10.1016/j.steroids.2024.109454.
  14. L. Schneider et al., “Dualities of the vitamin D in systemic sclerosis: a systematic literature review,” Adv. Rheumatol., vol. 61, no. 1, p. 34, 2021, doi: 10.1186/s42358-021-00192-6.
  15. M. A. Islam, S. S. Khandker, P. J. Kotyla, and R. Hassan, “Immunomodulatory Effects of Diet and Nutrients in Systemic Lupus Erythematosus (SLE): A Systematic Review.,” Front. Immunol., vol. 11, p. 1477, 2020, doi: 10.3389/fimmu.2020.01477.
  16. L. S. Tam et al., “Effects of vitamins C and E on oxidative stress markers and endothelial function in patients with systemic lupus erythematosus: a double blind, placebo controlled pilot study.,” J. Rheumatol., vol. 32, no. 2, pp. 275 LP – 282, Feb. 2005, [Online]. Available: http://www.jrheum.org/content/32/2/275.abstract
  17. J. Tian, D. Zhang, X. Yao, Y. Huang, and Q. Lu, “Global epidemiology of systemic lupus erythematosus: a comprehensive systematic analysis and modelling study,” Ann. Rheum. Dis., vol. 82, no. 3, pp. 351 LP – 356, Mar. 2023, doi: 10.1136/ard-2022-223035.
  18. G. Figueroa-Parra et al., “Treatment trends of systemic lupus erythematosus from 2007 to 2023 in the USA.,” Lupus Sci. Med., vol. 11, no. 2, Dec. 2024, doi: 10.1136/lupus-2024-001317.
  19. A. Gęgotek and E. Skrzydlewska, “Antioxidative and Anti-Inflammatory Activity of Ascorbic Acid,” Antioxidants, vol. 11, no. 10. 2022. doi: 10.3390/antiox11101993.
  20. C. R. Trankle et al., “Vitamin C Intravenous Treatment In the Setting of Atrial Fibrillation Ablation: Results From the Randomized, Double‐Blinded, Placebo‐Controlled CITRIS‐AF Pilot Study,” J. Am. Heart Assoc., vol. 9, no. 3, p. e014213, Feb. 2020, doi: 10.1161/JAHA.119.014213.
  21. P. Katsimbri et al., “The Effect of Antioxidant and Anti-Inflammatory Capacity of Diet on Psoriasis and Psoriatic Arthritis Phenotype: Nutrition as Therapeutic Tool?,” Antioxidants (Basel, Switzerland), vol. 10, no. 2, Jan. 2021, doi: 10.3390/antiox10020157.
  22. M. Tampa, M. I. Mitran, C. I. Mitran, C. Matei, and S. R. Georgescu, “Psoriasis: What Is New in Markers of Disease Severity?,” Medicina (Kaunas)., vol. 60, no. 2, Feb. 2024, doi: 10.3390/medicina60020337.
  23. R. Bilski, D. Kupczyk, and A. Woźniak, “Oxidative Imbalance in Psoriasis with an Emphasis on Psoriatic Arthritis: Therapeutic Antioxidant Targets,” Molecules, vol. 29, no. 22. 2024. doi: 10.3390/molecules29225460.
  24. S. Al-Katib, H. Al-Wakeel, and R. Al-Rawaf, “Role of vitamin c as antioxidant in psoriasis patients treated with NB-UVB phototherapy,” Indian J. Public Heal. Res. Dev., vol. 9, p. 375, Jan. 2018, doi: 10.5958/0976-5506.2018.01372.4.
  25. R. R. Dutta, T. Kumar, and N. Ingole, “Diet and Vitiligo: The Story So Far.,” Cureus, vol. 14, no. 8, p. e28516, Aug. 2022, doi: 10.7759/cureus.28516.
  26. A. Zheleva, G. Nikolova, Y. Karamalakova, E. Hristakieva, R. Lavcheva, and V. Gadjeva, “Comparative study on some oxidative stress parameters in blood of vitiligo patients before and after combined therapy,” Regul. Toxicol. Pharmacol., vol. 94, pp. 234–239, 2018, doi: https://doi.org/10.1016/j.yrtph.2018.02.008.
  27. R. Speeckaert, V. Bulat, M. M. Speeckaert, and N. van Geel, “The Impact of Antioxidants on Vitiligo and Melasma: A Scoping Review and Meta-Analysis.,” Antioxidants (Basel, Switzerland), vol. 12, no. 12, Dec. 2023, doi: 10.3390/antiox12122082.
  28. S. Padmakar, G. A. Kumar, N. Khurana, S. Kumari, and B. Pal, “Efficacy and safety of natural Aloe Vera gel in the treatment of stable vitiligo,” Clin. Epidemiol. Glob. Heal., vol. 22, p. 101332, 2023, doi: https://doi.org/10.1016/j.cegh.2023.101332.
  29. M. Fallah, R. Abedini, S. A. Mahiabadi, S. Montazeri, M. J. Hosseinzadeh-Attar, and S. Ebrahimpour-Koujan, “The effect of vitamin C on oxidative stress indices and skin regimentation of vitiligo patients.,” Arch. Dermatol. Res., vol. 315, no. 9, pp. 2655–2660, Nov. 2023, doi: 10.1007/s00403-023-02687-2.
  30. E. Di Pierro and F. Granata, “Nutrients and Porphyria: An Intriguing Crosstalk.,” Int. J. Mol. Sci., vol. 21, no. 10, May 2020, doi: 10.3390/ijms21103462.
  31. K. Wang, H. Jiang, W. Li, M. Qiang, T. Dong, and H. Li, “Role of Vitamin C in Skin Diseases,” Front. Physiol., vol. 9, 2018, [Online]. Available: https://www.frontiersin.org/journals/physiology/articles/10.3389/fphys.2018.00819
  32. P. Ventura et al., “Hyperhomocysteinemia in patients with acute porphyrias: A potentially dangerous metabolic crossroad?,” Eur. J. Intern. Med., vol. 79, pp. 101–107, 2020, doi: https://doi.org/10.1016/j.ejim.2020.04.002.
  33. Z. Lu et al., “Atopic dermatitis and risk of autoimmune diseases: a systematic review and meta-analysis,” Allergy, Asthma Clin. Immunol., vol. 17, no. 1, p. 96, 2021, doi: 10.1186/s13223-021-00597-4.
  34. L. U. Ivert, C.-F. Wahlgren, B. Lindelöf, H. Dal, M. Bradley, and E. K. Johansson, “Association between atopic dermatitis and autoimmune diseases: a population-based case-control study.,” Br. J. Dermatol., vol. 185, no. 2, pp. 335–342, Aug. 2021, doi: 10.1111/bjd.19624.
  35. J. Ahn et al., “Unraveling the link between atopic dermatitis and autoimmune diseases in children: Insights from a large-scale cohort study with 15-year follow-up and shared gene ontology analysis,” Allergol. Int., vol. 73, no. 2, pp. 243–254, 2024, doi: https://doi.org/10.1016/j.alit.2023.12.005.
  36. S. Lee et al., “NXP081, DNA Aptamer–Vitamin C Complex Ameliorates DNFB-Induced Atopic Dermatitis in Balb/c Mice,” Nutrients, vol. 15, no. 19. 2023. doi: 10.3390/nu15194172.
  37. K. Kitahata et al., “Anti-allergic effect of ascorbic acid derivative DDH-1 in a mouse model of atopic dermatitis,” Exp. Dermatol., vol. 31, no. 8, pp. 1234–1242, Aug. 2022, doi: https://doi.org/10.1111/exd.14578.
  38. Y.-H. Chiu, Y.-W. Wu, J.-I. Hung, and M.-C. Chen, “Epigallocatechin gallate/L-ascorbic acid–loaded poly-γ-glutamate microneedles with antioxidant, anti-inflammatory, and immunomodulatory effects for the treatment of atopic dermatitis,” Acta Biomater., vol. 130, pp. 223–233, 2021, doi: https://doi.org/10.1016/j.actbio.2021.05.032.
  39. A. M. Porro, C. A. Seque, M. C. C. Ferreira, M. M. Simões, and S. Enokihara, “Pemphigus vulgaris*,” An. Bras. Dermatol., vol. 94, no. 3, pp. 264–278, 2019, doi: https://doi.org/10.1590/abd1806-4841.20199011.
  40. C. A. Carver, M. Kalesinskas, and A. R. Ahmed, “Current biologics in treatment of pemphigus foliaceus: a systematic review,” Front. Immunol., vol. 14, 2023, [Online]. Available: https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2023.1267668
  41. K. M. Ingold CJ, Sathe NC, “Pemphigus Vulgaris,” in StatPearls [Internet]. Treasure Island (FL), 2025. [Online]. Available: https://www.ncbi.nlm.nih.gov/books/NBK560860/
  42. A. M. Malik, S. Tupchong, S. Huang, A. Are, S. Hsu, and K. Motaparthi, “An Updated Review of Pemphigus Diseases.,” Medicina (Kaunas)., vol. 57, no. 10, Oct. 2021, doi: 10.3390/medicina57101080.
  43. M. Kutwin, M. Kądziela, T. Stein, M. Kraska-Gacka, A. Woźniacka, and A. Żebrowska, “Senear–Usher Syndrome or Coexistence of SLE with Pemphigus Vulgaris—A Case Report with Literature Review,” Journal of Clinical Medicine, vol. 14, no. 2. 2025. doi: 10.3390/jcm14020409.
  44. M. Yousefi et al., “URIC ACID: A NEW ANTIOXIDANT IN PATIENTS WITH PEMPHIGUS VULGARIS,” Indian J. Dermatol., vol. 56, no. 3, 2011, [Online]. Available: https://journals.lww.com/ijd/fulltext/2011/56030/uric_acid__a_new_antioxidant_in_patients_with.5.aspx
  45. D. Opriș-Belinski et al., “Trace Element Deficiency in Systemic Sclerosis—Too Much Effort for Some Traces?,” Nutrients, vol. 16, no. 13. 2024. doi: 10.3390/nu16132053.
  46. M. M. Appiah, N. Bohrer, A. Galati, C. Vuong, S. M. Tucker, and G. Hightower, “Vitamin C deficiency presenting as pseudoscleroderma in a pediatric patient with food aversion.,” JAAD case reports, vol. 44, pp. 82–84, Feb. 2024, doi: 10.1016/j.jdcr.2023.12.008.
  47. N. Brezovec et al., “Disturbed Antioxidant Capacity in Patients with Systemic Sclerosis Associates with Lung and Gastrointestinal Symptoms,” Biomedicines, vol. 11, no. 8. 2023. doi: 10.3390/biomedicines11082110.
  48. W. M. Qudsiya Z, “Dermatomyositis,” in StatPearls [Internet]. Treasure Island (FL), StatPearls Publishing, 2023. [Online]. Available: https://www.ncbi.nlm.nih.gov/books/NBK558917/
  49. C. E. Bax, S. Maddukuri, A. Ravishankar, L. Pappas-Taffer, and V. P. Werth, “Environmental triggers of dermatomyositis: a narrative review.,” Ann. Transl. Med., vol. 9, no. 5, p. 434, Mar. 2021, doi: 10.21037/atm-20-3719.
  50. Z.-S. Jin, X.-R. Tao, and Z.-X. Wang, “A case report of dermatomyositis mimicking myasthenia gravis,” Medicine (Baltimore)., vol. 102, no. 50, 2023, [Online]. Available: https://journals.lww.com/md-journal/fulltext/2023/12150/a_case_report_of_dermatomyositis_mimicking.57.aspx
  51. M. KODAMA and M. KODAMA, “The Autoimmune Disease Complex Interstitial Pneumonia / Dermatomyositis in the Light of Endocrinology and Cancer Epidemiology,” In Vivo (Brooklyn)., vol. 23, no. 2, pp. 353 LP – 356, Mar. 2009, [Online]. Available: http://iv.iiarjournals.org/content/23/2/353.abstract
  52. S. Na, L. Zhang, L. Kou, J. Xu, and L. Gang, “A case report of Henoch–Schönlein purpura in the elderly complicated by multisystem involvement,” Medicine (Baltimore)., vol. 104, no. 1, 2025, [Online]. Available: https://journals.lww.com/md-journal/fulltext/2025/01030/a_case_report_of_henoch_sch_nlein_purpura_in_the.32.aspx
  53. P. G. Brodeur, G. Aghagoli, A. Pugacheva, A. R. Goel, O. D. Maguire, and K. A. Dewar, “Vitamin C Deficiency as a Mimicker of Vasculitis: A Case,” Ann. Intern. Med. Clin. Cases, vol. 2, no. 5, p. e221191, May 2023, doi: 10.7326/aimcc.2022.1191.
  54. K. K. Verma, F. Z. Deligonul, H. Chen, and M. Tarbox, “Vitamin C Deficiency Masquerading as Vasculitis in a Patient With Crohn’s Disease.,” Cureus, vol. 16, no. 2, p. e55295, Feb. 2024, doi: 10.7759/cureus.55295.
  55. H. L. Kassa et al., “Scurvy masquerading as IgA vasculitis,” Pediatr. Rheumatol., vol. 22, no. 1, p. 56, 2024, doi: 10.1186/s12969-024-00992-2.
  56. C. Bachmeyer et al., “Extensive purpuric lesions due to vitamin C deficiency and leucocytoclastic vasculitis as the initial sign of lung adenocarcinoma,” Clin. Exp. Dermatol., vol. 44, no. 3, pp. e53–e54, Apr. 2019, doi: 10.1111/ced.13918.
  57. S. A. Elman, D. R. Mazori, and J. F. Merola, “Pseudovasculitis: an etiology not to miss,” Clin. Rheumatol., vol. 40, no. 6, pp. 2505–2506, 2021, doi: 10.1007/s10067-020-05548-9.
  58. K. Geetha, K. Anil, K. Sowmya, and K. Ashwin, “Assessment of serum levels of ascorbic acid and malondialdehyde as oxidative stress marker in patients with oral lichen planus,” International Journal of Clinical Biochemistry and Research, vol. 2021. IP Innovative Publication , p. 13108, 2021. doi: 2394-6377.
  59. F. Rezazadeh and S. Haghighat, “Serum Vitamin Profile in Oral Lichen Planus Patients in Southwest of Iran.,” Biomed Res. Int., vol. 2021, p. 8627435, 2021, doi: 10.1155/2021/8627435.
  60. K. Tsunoda et al., “Low serum levels of vitamin C in patients with oral lichen planus: a case-control study,” J. Oral Maxillofac. Surgery, Med. Pathol., vol. 34, no. 4, pp. 440–444, 2022, doi: https://doi.org/10.1016/j.ajoms.2021.11.001.
  61. S. R. Georgescu et al., “Oxidative Stress in Cutaneous Lichen Planus—A Narrative Review,” Journal of Clinical Medicine, vol. 10, no. 12. 2021. doi: 10.3390/jcm10122692.